Abhay Asthana
Overview
Explore the profile of Abhay Asthana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shilakari Asthana G, Asthana A, Singh D, Sharma P
J Drug Deliv
. 2016 Aug;
2016:9324567.
PMID: 27478643
The present study aimed to investigate the delivery potential of Etodolac (ETD) containing topical niosomal gel. Niosomal formulations were prepared by thin film hydration method at various ratios of cholesterol...
2.
Shilakari Asthana G, Sharma P, Asthana A
Scientifica (Cairo)
. 2016 Jun;
2016:6492953.
PMID: 27293976
The present study was focused on formulating and evaluating clarithromycin (CLR) containing niosomal formulation for in vitro and in vivo pharmacokinetic behavior. Niosomal formulations (empty and drug loaded) were prepared...
3.
Bansal S, Beg S, Garg B, Asthana A, Asthana G, Singh B
AAPS PharmSciTech
. 2015 Nov;
17(5):1086-99.
PMID: 26527606
The objective of the present studies was systematic development of floating-bioadhesive gastroretentive tablets of cefuroxime axetil employing rational blend of hydrophilic polymers for attaining controlled release drug delivery. As per...
4.
Wadhwa J, Asthana A, Shilakari G, Chopra A, Singh R
ScientificWorldJournal
. 2015 Apr;
2015:541510.
PMID: 25861680
The present study aimed to develop and optimize a nanoemulsifying preconcentrate formulation of curcumin with good emulsification ability and optimal globule size, for controlled targeting in colon. Content of formulation...
5.
Wadhwa J, Asthana A, Gupta S, Shilkari Asthana G, Singh R
ScientificWorldJournal
. 2014 Dec;
2014:516069.
PMID: 25525620
The purpose of the present study was to formulate polymeric self-emulsifying curcumin nanocapsules with high encapsulation efficiency, good emulsification ability, and optimal globule size for localized targeting in the colon....
6.
Shilakari Asthana G, Asthana A, Kohli D, Vyas S
Biomed Res Int
. 2014 Jul;
2014:526391.
PMID: 25057492
The therapeutic potential of antisense oligonucleotides (ASODN) is primarily dependent upon its safe and efficient delivery to specific cells overcoming degradation and maximizing cellular uptake in vivo. The present study...
7.
Bansal S, Beg S, Asthana A, Garg B, Shilakari Asthana G, Kapil R, et al.
Drug Deliv
. 2014 May;
23(2):437-51.
PMID: 24865292
The objectives of present studies were to develop the systematically optimized multiple-unit gastroretentive microballoons, i.e. hollow microspheres of itopride hydrochloride (ITH) employing quality by design (QbD)-based approach. Initially, the patient-centric...
8.
Agarwal A, Gupta U, Asthana A, Jain N
Biomaterials
. 2009 Apr;
30(21):3588-96.
PMID: 19344947
The purpose of the present investigation was to evaluate the potential of surface engineered polypropylene imine (PPI) dendrimers as nanoscale drug delivery units for site-specific delivery of a model anti-cancer...
9.
Singh P, Gupta U, Asthana A, Jain N
Bioconjug Chem
. 2008 Oct;
19(11):2239-52.
PMID: 18950215
Ligand-mediated targeting of drugs especially in anticancer drug delivery is an effective approach. Dendrimers, due to unique surface topologies, can be a choice in this context. In the present study,...
10.
Agarwal A, Asthana A, Gupta U, Jain N
J Pharm Pharmacol
. 2008 May;
60(6):671-88.
PMID: 18498702
Tumour is a morbid state, characterized by spontaneous outgrowth of an abnormal mass of cells. The evolution of tumours is random, disorganized, a condition of numerous mutations. The properties are...